Literature DB >> 16995595

Genetic characteristics of dementia in Taiwan.

Hsin-Hung Chen1, Chaur-Jong Hu.   

Abstract

The most common causes of dementia in Taiwan are Alzheimer's disease (AD) followed by vascular dementia (VaD). Several genetic studies have documented an increased risk of AD among apolipoprotein E gene allele 4 (ApoE4) carriers in Taiwanese (ethnic Chinese). Although ApoE4 is considered the most important risk factor for AD, the ApoE4 allele frequency is lower in Taiwanese (around 7%), than that in most Caucasian populations (over 10%). This phenomenon raises the hypothesis that low ApoE4 allele frequency contributes to the low prevalence of AD in Taiwanese. Other studies of the genetic impacts on modulation or regulation of manifestations, progression, and treatment response of AD in Taiwan have been inconclusive. Familial AD, which is conferred by PS1 gene mutation has been identified. There were very few studies of fronto-temporal dementia (FTD) or dementia with Lewy body (DLB) in Taiwan. Genetic studies of VaD remain limited and only NOTCH3 gene mutation has been detected in a Taiwanese cerebral autosomal dominant arteriopathy with subcortical infarct and leukoencephalopathy (CADASIL) family. Limited data indicated that non- ApoE4-associated AD may represent a larger proportion of AD in Taiwanese, suggesting the existence of novel genetic factors which remain to be identified.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16995595

Source DB:  PubMed          Journal:  Acta Neurol Taiwan        ISSN: 1028-768X


  3 in total

1.  Frontotemporal dementia in eight Chinese individuals.

Authors:  Steven Z Chao; Howard J Rosen; Virgina Azor; Hilary Ong; Marian M Tse; Ngan Betty Lai; Craig E Hou; William W Seeley; Bruce L Miller; Brandy R Matthews
Journal:  Neurocase       Date:  2012-06-14       Impact factor: 0.881

Review 2.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Authors:  Raj N Kalaria; Gladys E Maestre; Raul Arizaga; Robert P Friedland; Doug Galasko; Kathleen Hall; José A Luchsinger; Adesola Ogunniyi; Elaine K Perry; Felix Potocnik; Martin Prince; Robert Stewart; Anders Wimo; Zhen-Xin Zhang; Piero Antuono
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

3.  Galantamine plasma concentration and cognitive response in Alzheimer's disease.

Authors:  Yi-Ting Lin; Mei-Chuan Chou; Shyh-Jong Wu; Yuan-Han Yang
Journal:  PeerJ       Date:  2019-05-02       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.